Kirsten Craven

Selecting an LC-MS system for quantitation of pharmaceutical drug development

Oct 29, 2024 | Blogs, Echo MS, Pharma, QTRAP / Triple Quad, ZenoTOF 7600 system | 0 comments

Read time: 2 minutes

Introduction

Drug development is a challenging process that requires diverse analytical solutions and the expertise of research scientists.

Within drug discovery confident go/no-go decisions need to be made as quickly as possible. Often, highly sensitive techniques are needed to accurately monitor concentrations of biomarkers, therapeutic candidates, and their metabolites. QA/QC laboratories need consistent performance everyday over many years.

Pharmaceutical quantitation solution guide

We understand you are busy, needing to prioritize running instruments, reporting results and managing your laboratory to meet deadlines. We created a solution guide to explain how SCIEX systems fit in the drug development pipeline to save you time evaluating options.

The guide covers bio/pharmaceutical quantitative assays from discovery to QA/QC, for large and small molecules. Discussing challenges regularly faced by scientists, along with potential solutions.

Download the guide >

What’s inside the guide?

The guide includes comprehensive chapters addressing multiple challenges and solutions regularly faced in drug development.

Discovery

Identify hits with accuracy and speed
Easily report results with end-to-end workflows
Measure molecular masses for small and large drug candidates

Development (Small and large molecules)

Acquire reliable and sensitive bioanalytical data
Perform studies with confidence using compliance-ready software
Get support from a team of dependable experts

Regulatory solutions

Minimize regulatory risk with complete system solutions
Ensure compliance for instruments through installation and maintenance qualifications
Reduce human error with user access levels

QA/QC and lot release

Quickly identify deviations from product specifications
Flexible system configurations that can be tailored to an ever-evolving regulatory landscape
Expert application and service support

Products

Discover systems at the forefront of quantitative performance
Benefit from compliance-ready software and trusted service partners
Ensure your results are the best they can be

Download the guide here >

Overcoming uncertainty in your PFAS analysis

Just like gum on the bottom of a shoe, the existence of per- and poly-fluorinated alkyl substances (PFAS) in our environment is a sticky one. If you’re in the field of environmental testing, then you’re all too familiar with the threat these substances have on public health. While we have learned a lot about them over the years, there is still much more to understand. With the right detection methods, we can gather the information we need to empower us to make informed decisions on reducing the risks they impose.

6 Signs it’s time for a new vendor

A lab’s success depends on many factors from instrument quality to efficient operations, including being partnered with the right vendor. A vendor is more than just a supplier. They should provide you with a high-level quality of support in maximizing the lifespan and performance of your systems, reducing downtime, enhancing ROI and more. How do you know if you’re partnered with the right one? Here are six signs it might be time to find someone new.

Plasmid manufacturing: Setting up your CGT programs for success

Plasmid DNA serves a variety of purposes, from critical starting material for proteins, mRNA, viral vectors, and drug substances. Below, Dr. Emma Bjorgum, the Vice President of Client Services of the DNA Business Unit at Aldevron and an expert in plasmid manufacturing, provided insights into the process and an outlook on the future.

Posted by

Kirsten Craven

Kirsten Craven is the Senior Global Marketing Manager for Pharma global strategic marketing at SCIEX. In this role, she manages strategic marketing for the pharmaceutical industry. Kirsten spent the first part of her career working in laboratories across multiple industries before moving into product management, and most recently pharma marketing.

0 Comments